BIBLIO is the largest independent book marketplace in the world, with over 100 million books.

Skip to content

No image available

Artificial Intelligence and Machine Learning for Digital Pathology: State-of-the-Art and Future Challenges (Lecture Notes in Computer Science)

No image available
No image available

Artificial Intelligence and Machine Learning for Digital Pathology: State-of-the-Art and Future Challenges (Lecture Notes in Computer Science) Paperback - 2020

by Goebel, Randy (Editor) / Holzinger, Andreas (Editor) / Mengel, Michael (Editor) / Müller, Heimo (Editor)

Add to wish list
  • New
  • Paperback
New

Description

Springer, 2020. Paperback. New. 356 pages. 9.25x6.10x0.94 inches.
Ask the seller a question Add to wish list
A$228.69
A$29.16 Delivery to USA
Standard delivery: 7 to 14 days
More delivery options
Ships from Revaluation Books (Devon, United Kingdom)

Details

  • Title Artificial Intelligence and Machine Learning for Digital Pathology: State-of-the-Art and Future Challenges (Lecture Notes in Computer Science)
  • Author Goebel, Randy (Editor) / Holzinger, Andreas (Editor) / Mengel, Michael (Editor) / Müller, Heimo (Editor)
  • Binding Paperback
  • Condition New
  • Pages 341
  • Volumes 1
  • Language ENG
  • Publisher Springer
  • Publication date 2020
  • Features Annotated
  • Bookseller's Inventory # x-3030504018
  • ISBN 9783030504014 / 3030504018
  • Weight 1.1 lbs (0.50 kg)
  • Dimensions 9.1 x 7.7 x 0.6 in (23.11 x 19.56 x 1.52 cm)
  • Category Computers - General Information
  • Quantity available 2

About Revaluation Books Devon, United Kingdom

Biblio member since 2020

General bookseller of both fiction and non-fiction.

Terms of Sale: 30 day return guarantee, with full refund including original shipping costs for up to 30 days after delivery if an item arrives misdescribed or damaged.

Browse books from Revaluation Books

Reader reviews for Artificial Intelligence and Machine Learning for Digital Pathology: State-of-the-Art and Future Challenges (Lecture Notes in Computer Science)

From the publisher

Data driven Artificial Intelligence (AI) and Machine Learning (ML) in digital pathology, radiology, and dermatology is very promising. In specific cases, for example, Deep Learning (DL), even exceeding human performance. However, in the context of medicine it is important for a human expert to verify the outcome. Consequently, there is a need for transparency and re-traceability of state-of-the-art solutions to make them usable for ethical responsible medical decision support.
Moreover, big data is required for training, covering a wide spectrum of a variety of human diseases in different organ systems. These data sets must meet top-quality and regulatory criteria and must be well annotated for ML at patient-, sample-, and image-level. Here biobanks play a central and future role in providing large collections of high-quality, well-annotated samples and data. The main challenges are finding biobanks containing ''fit-for-purpose'' samples, providing quality related meta-data, gaining access to standardized medical data and annotations, and mass scanning of whole slides including efficient data management solutions.


From the rear cover

Data driven Artificial Intelligence (AI) and Machine Learning (ML) in digital pathology, radiology, and dermatology is very promising. In specific cases, for example, Deep Learning (DL), even exceeding human performance. However, in the context of medicine it is important for a human expert to verify the outcome. Consequently, there is a need for transparency and re-traceability of state-of-the-art solutions to make them usable for ethical responsible medical decision support.
Moreover, big data is required for training, covering a wide spectrum of a variety of human diseases in different organ systems. These data sets must meet top-quality and regulatory criteria and must be well annotated for ML at patient-, sample-, and image-level. Here biobanks play a central and future role in providing large collections of high-quality, well-annotated samples and data. The main challenges are finding biobanks containing ''fit-for-purpose'' samples, providing quality related meta-data, gaining access to standardized medical data and annotations, and mass scanning of whole slides including efficient data management solutions.


tracking-